close
MENU
4 mins to read

Synlait: FDA approval for Munchkin infant formula is imminent

The US is a less cluttered market for imported infant formula.

Jenny Ruth
Thu, 20 Jul 2017

Synlait Milk says the US Food & Drug Administration's delayed approval of Munchkin’s stage one infant formula product to be sold in America is imminent.

The Munchkin “grass fed” infant formula, which is being manufactured by Synlait, was expected to have been launched in May.

The FDA approved

Want to read more? It's easy.

Choose your best value subscription option

Student

Exclusive offer for uni students studying at a New Zealand university (valued at $499).
Individual
Group membership
NBR Marketplace

Yearly Premium Online Subscription

NZ$499.00 / yearly

Monthly Premium Online Subscription

NZ$44.95 / monthly

Smartphone Only Subscription

NZ$24.95 / monthly

Premium Group Membership 10 Users

NZ$350+GST / monthly

$35 per user - Pay by monthly credit card debit

Premium Group Membership 20 Users

NZ$600+GST / monthly

$30 per user - Pay by monthly credit card debit

Premium Group Membership 50 Users

NZ$1250+GST / monthly

$25 per user - Pay by monthly credit card debit

Premium Group Membership 100 Users

NZ$1875+GST / monthly

$18.75 per user - Pay by monthly credit card debit

Yearly Premium Online Subscription + NBR Marketplace

NZ$499.00 / yearly

Already have an account? Login
Jenny Ruth
Thu, 20 Jul 2017
© All content copyright NBR. Do not reproduce in any form without permission, even if you have a paid subscription.
Synlait: FDA approval for Munchkin infant formula is imminent
68591
true